Merck, Sun Pharma Form Generics Joint Venture

Law360, New York (April 11, 2011, 2:43 PM EDT) -- Merck & Co. Inc. and Indian generic-drug maker Sun Pharmaceutical Industries Ltd. on Monday announced a joint venture to develop, manufacture and sell branded generics in emerging markets.

Merck's pairing with Sun Pharma is just the latest example of a Western drug powerhouse teaming with an international generics maker to gain a foothold in emerging drug markets around the world, which Merck says will drive up to 90 percent of the world's pharmaceutical growth. Around 75 percent of that growth is likely to come in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.